Company intelligence / Profile preview

Nova Argentia

Gorgonzola/Milan area, Lombardy, Italynovaargentia.it ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Nova Argentia, founded in Milan in 1947, has evolved from a small galenical laboratory into a major Italian pharmaceutical manufacturer. The company develops and produces drugs, medical devices, food supplements, galenicals, and para-pharmaceuticals. Since joining the AEFFE Farmaceutici Group in 2013, it has expanded production capacity. All manufacturing occurs at three sites in Italy with distribution across Italy and more than twenty-five countries. The product portfolio includes over fifty AIFA-authorized medicinal products as well as numerous supplements and medical devices for general health maintenance

Therapeutic areas: Other
Modalities: Small moleculeMedical deviceFood supplementGalenicals
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Nova Argentia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nova Argentia.

Explore the full profile